Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

1.

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE.

PLoS One. 2010 Sep 7;5(9):e12562. doi: 10.1371/journal.pone.0012562.

2.

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, Chan T, Gentleman B, Purych D, Gardy J, Patrick DM, Brunham RC, De Serres G, Petric M.

J Infect Dis. 2011 Jan 15;203(2):158-67. doi: 10.1093/infdis/jiq039.

3.

Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.

Lemaitre M, Leruez-Ville M, De Lamballerie XN, Salez N, Garrone P, Fluckiger AC, Klatzmann D, Carrat F.

Clin Microbiol Infect. 2011 May;17(5):732-7. doi: 10.1111/j.1469-0691.2010.03352.x. Epub 2010 Oct 29.

4.

Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.

Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, Seston M, Lina B, Nougairede A, Charrel R, Flahault A, de Lamballerie X.

Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.

5.

Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period.

Dudareva S, Schweiger B, Thamm M, Höhle M, Stark K, Krause G, Buda S, Haas W.

PLoS One. 2011;6(6):e21340. doi: 10.1371/journal.pone.0021340. Epub 2011 Jun 20.

6.

Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.

Cox CM, Goodin K, Fisher E, Dawood FS, Hamilton JJ, Leparc GF, Gray M, Nelson L, Borse RH, Singleton JA, Reed C, Balish AL, Katz JM, Hopkins RS, Fry AM.

PLoS One. 2011;6(12):e29301. doi: 10.1371/journal.pone.0029301. Epub 2011 Dec 20.

7.

Differential diagnosis of pandemic (H1N1) 2009 infection by detection of haemagglutinin with an enzyme-linked immunoassay.

Yuan Q, Cheng XD, Yang BC, Zheng QB, Chen YX, Chen QR, Zeng F, Zhang R, Ge SX, Hao XK, Chen H, Zhang J, Xia NS.

Clin Microbiol Infect. 2011 Oct;17(10):1574-80. doi: 10.1111/j.1469-0691.2010.03413.x. Epub 2011 Jan 11.

8.

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, Zambon M, Miller E.

Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.

9.

Epidemiological and serological surveillance of human pandemic influenza A virus infections during 2009-2010 in Thailand.

Prachayangprecha S, Makkoch J, Vuthitanachot C, Vuthitanachot V, Payungporn S, Chieochansin T, Theamboonlers A, Poovorawan Y.

Jpn J Infect Dis. 2011;64(5):377-81.

10.

Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.

Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.

HIV Med. 2012 Jul;13(6):352-7. doi: 10.1111/j.1468-1293.2011.00987.x. Epub 2012 Feb 2.

11.

Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.

McVernon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, Hyland C, Faddy H, Carolan L, Barr I, Kelso A.

Euro Surveill. 2010 Oct 7;15(40). pii: 19678.

12.

Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.

Zhou Y, Ng DM, Seto WH, Ip DK, Kwok HK, Ma ES, Ng S, Lau LL, Peiris JS, Cowling BJ.

PLoS One. 2011;6(11):e27169. doi: 10.1371/journal.pone.0027169. Epub 2011 Nov 10.

13.

[A survey of levels of antibodies against influenza viruses in the population of Wuxi City].

You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Oct;25(5):351-4. Chinese.

PMID:
22338222
14.

Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.

Tsai TF, Pedotti P, Hilbert A, Lindert K, Hohenboken M, Borkowski A, Groth N, da Silva LJ, Kyaw MH.

Euro Surveill. 2010 Jul 29;15(30). pii: 19624.

15.

Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.

Subelj V, Prosenc K, Sočan M.

Wien Klin Wochenschr. 2012 Mar;124(5-6):177-80. doi: 10.1007/s00508-012-0126-0. Epub 2012 Feb 15.

PMID:
22327938
16.

Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population.

Chi CY, Liu CC, Lin CC, Wang HC, Cheng YT, Chang CM, Wang JR.

Clin Vaccine Immunol. 2010 Dec;17(12):1958-62. doi: 10.1128/CVI.00212-10. Epub 2010 Sep 28.

17.

Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.

Poeppl W, Poeppl G, Hunger M, Tobudic S, Winkler H, Faas A, Mooseder G, Burgmann H.

J Med Virol. 2012 Sep;84(9):1331-4. doi: 10.1002/jmv.23337.

PMID:
22825809
18.

Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.

Booy R, Khandaker G, Heron LG, Yin J, Doyle B, Tudo KK, Hueston L, Gilbert GL, Macintyre CR, Dwyer DE.

Med J Aust. 2011 Jan 3;194(1):19-23.

PMID:
21449863
19.

The seroprevalence of pandemic influenza H1N1 (2009) virus in China.

Xu C, Bai T, Iuliano AD, Wang M, Yang L, Wen L, Zeng Y, Li X, Chen T, Wang W, Hu Y, Yang L, Li Z, Zou S, Li D, Wang S, Feng Z, Zhang Y, Yu H, Yang W, Wang Y, Widdowson MA, Shu Y.

PLoS One. 2011 Apr 21;6(4):e17919. doi: 10.1371/journal.pone.0017919.

20.

Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009.

Dawood FS, Hope KG, Durrheim DN, Givney R, Fry AM, Dalton CB.

PLoS One. 2010 Mar 25;5(3):e9880. doi: 10.1371/journal.pone.0009880.

Supplemental Content

Support Center